As Cancer Immunotherapy Evolves, Challenges Compound for Diagnostic Development – GenomeWeb
|
As Cancer Immunotherapy Evolves, Challenges Compound for Diagnostic Development
GenomeWeb NEW YORK (GenomeWeb) – At various sessions during Cambridge Healthtech Institute’s Molecular Medicine Tri-Conference earlier this month, representatives from the diagnostics arena, pharmaceutical companies, and the medical oncology field discussed the … |
|
Bioengineering Team’s ‘Circuit’ Work May Benefit Gene Therapy
University of Texas at Dallas (press release) “Synthetic biology is important for gene therapy applications, and our methodology may assist in building more robust and reliable therapeutics in the future,” Bleris said. The study was funded by the National Science Foundation. Other UT Dallas … |
University of Texas at Dallas (press release) |
Bioengineering Team’s ‘Circuit’ Work May Benefit Gene Therapy
University of Texas at Dallas (press release) “Synthetic biology is important for gene therapy applications, and our methodology may assist in building more robust and reliable therapeutics in the future,” Bleris said. The study was funded by the National Science Foundation. Other UT Dallas … |
|
UNC Lineberger researchers identify molecular target for brain cancer that could control tumor growth and lead to …
UNC News The study is part of a research program launched at UNC Lineberger to develop personalized immune-based treatments called chimeric antigen receptor T cell, or CAR-T, therapies. This approach involves removing a patient’s immune cells and genetically … |